Axcelead covers Affinity Selection-Mass Spectrometry (AS-MS) and RapidFire-MS technologies, enabling quick hit identification for challenging targets. We have a proven track record in finding potent small molecule binders for FMN riboswitch RNA. Our expertise in RapidFire-MS has led to high-throughput screening successes, including the discovery of a selective LDHB inhibitor. Our proficiency in MS technologies enhances hit identification and optimization, making them a dependable partner for early drug discovery and innovation.